AJOONI — Ajooni Biotech Balance Sheet
0.000.00%
Last trade - 00:00- IN₹1.30bn
- IN₹1.16bn
- IN₹801.15m
- 38
- 32
- 74
- 45
Annual balance sheet for Ajooni Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1.24 | 2.44 | 0.574 | 4.93 | 4.28 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 139 | 157 | 160 | 246 | 165 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 175 | 214 | 219 | 347 | 323 |
| Net Property, Plant And Equipment | 20.7 | 51.6 | 62.1 | 65.5 | 112 |
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 231 | 280 | 290 | 587 | 475 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 58.5 | 105 | 101 | 152 | 30.1 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 71.8 | 124 | 126 | 171 | 48.1 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Total Equity | 159 | 157 | 164 | 417 | 427 |
| Total Liabilities & Shareholders' Equity | 231 | 280 | 290 | 587 | 475 |
| Total Common Shares Outstanding |